Skip to main content
. 2023 Jun 3;15:95. doi: 10.1186/s13148-023-01511-y

Table 1.

Overview of the sample composition and tumour characteristics within each of the four Consensus Clusters derived from genome-wide DNA methylation profiling of six CRC subtypes (reference groups)

Consensus cluster 1 Consensus cluster 2 Consensus cluster 3 Consensus cluster 4
Number of CRCs 20 3 9 6
Age at CRC diagnosis (mean ± s.d) 38.7 ± 10.6 45.9 ± 12.8 65.5 ± 9.65 39.2 ± 11.3
MLH1 promoter methylationa (mean ± s.d) 0.076 ± 0.02 0.082 ± 0.02 0.548 ± 0.089 0.761 ± 0.045
CIMPb (% positive) 0 (0%) 1 (33%) 9 (100%) 0 (0%)
Mean methylation across the VM-CpGsc 0.32 0.42 0.45 0.35
Lynch syndrome (n = 9) 8 1 0 0
MMR-proficient CRC (n = 9) 8 1 0 0
Double somatic MMR mutation CRC (n = 5) 4 1 0 0
Sporadic MLH1 methylated CRCs (n = 9) 0 0 9 0
MLH1 primary epimutation (n = 5) 0 0 0 4
MLH1 secondary epimutation (n = 1) 0 0 0 2

aMean methylation (β-values) across the regulatory C region of MLH1

bCIMP was determined by the methylation levels of CpG probes overlapping five previously defined genes [40]

cMean methylation levels across the 77,113 most variably methylated CpGs (VM-CpGs), which was used for defining the Consensus Clusters. s.d.—standard deviation, VM-CpGs—(77,113) variably methylated CpGs defined by having high variation in the methylation patterns as ranked by standard deviation across 38 reference CRCs